Stoke Therapeutics, Inc. (STOK) Net income 2018–2025
Stoke Therapeutics, Inc. (STOK) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$6.9MFY2025 · since FY2018: -$12.5M → -$6.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.9M | +92.3% |
| FY2024 | -$89.0M | +15.0% |
| FY2023 | -$104.7M | -3.6% |
| FY2022 | -$101.1M | -17.8% |
| FY2021 | -$85.8M | -64.2% |
| FY2020 | -$52.2M | -61.6% |
| FY2019 | -$32.3M | -158.2% |
| FY2018 | -$12.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More STOK financial trends
STOK RevenueSTOK Net marginSTOK Gross profitSTOK Gross marginSTOK Operating incomeSTOK Operating marginSTOK Operating cash flowSTOK Free cash flowSTOK Capital expendituresSTOK Return on equitySTOK Stock buybacksSTOK Dividends paidSTOK Total assetsSTOK Total liabilitiesSTOK Shareholders’ equitySTOK overview →